↓ Skip to main content

Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

Overview of attention for article published in Journal of Clinical Oncology, September 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
policy
2 policy sources
twitter
7 X users
googleplus
1 Google+ user

Citations

dimensions_citation
720 Dimensions

Readers on

mendeley
557 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
Published in
Journal of Clinical Oncology, September 2012
DOI 10.1200/jco.2012.42.9597
Pubmed ID
Authors

Samuel Y. Ngan, Bryan Burmeister, Richard J. Fisher, Michael Solomon, David Goldstein, David Joseph, Stephen P. Ackland, David Schache, Bev McClure, Sue-Anne McLachlan, Joseph McKendrick, Trevor Leong, Cris Hartopeanu, John Zalcberg, John Mackay

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 557 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 7 1%
Japan 2 <1%
Ecuador 1 <1%
Greece 1 <1%
Italy 1 <1%
Unknown 545 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 96 17%
Other 70 13%
Student > Postgraduate 64 11%
Student > Ph. D. Student 51 9%
Student > Doctoral Student 44 8%
Other 121 22%
Unknown 111 20%
Readers by discipline Count As %
Medicine and Dentistry 354 64%
Agricultural and Biological Sciences 12 2%
Biochemistry, Genetics and Molecular Biology 9 2%
Nursing and Health Professions 9 2%
Immunology and Microbiology 6 1%
Other 23 4%
Unknown 144 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 January 2023.
All research outputs
#1,069,667
of 25,837,817 outputs
Outputs from Journal of Clinical Oncology
#2,595
of 22,229 outputs
Outputs of similar age
#6,078
of 191,447 outputs
Outputs of similar age from Journal of Clinical Oncology
#12
of 209 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,229 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,447 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 209 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.